Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino Acid (15) Peritoneal Dialysis Solution in Malnourished CAPD Patients
NCT06597201Phase 4Recruiting
- Sponsor
- Chengdu Qingshan Likang Pharmaceutical
- Start
- Aug 2024
- Primary completion
- Jun 2025
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of amino acid (15) peritoneal dialysis solution in Malnutrition, sponsored by Chengdu Qingshan Likang Pharmaceutical. Started Aug 2024; status: recruiting.
02
Drugs
amino acid (15) peritoneal dialysis solution
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT06597201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06597201.